About: Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Creator	Li, Bo Yang, Jing Liu, Lin Bi, Zhaohui Zhao, Faming Zhao, Yunhe Zhi, Lili Wang, ·
Source	Medline; PMC
abstract	BACKGROUND: Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection. The aim of this analysis is to determine the association of cardiovascular metabolic diseases with the development of COVID-19. METHODS: A meta-analysis of eligible studies that summarized the prevalence of cardiovascular metabolic diseases in COVID-19 and compared the incidences of the comorbidities in ICU/severe and non-ICU/severe patients was performed. Embase and PubMed were searched for relevant studies. RESULTS: A total of six studies with 1527 patients were included in this analysis. The proportions of hypertension, cardia-cerebrovascular disease and diabetes in patients with COVID-19 were 17.1%, 16.4% and 9.7%, respectively. The incidences of hypertension, cardia-cerebrovascular diseases and diabetes were about twofolds, threefolds and twofolds, respectively, higher in ICU/severe cases than in their non-ICU/severe counterparts. At least 8.0% patients with COVID-19 suffered the acute cardiac injury. The incidence of acute cardiac injury was about 13 folds higher in ICU/severe patients compared with the non-ICU/severe patients. CONCLUSION: Patients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the COVID-19. On the other hand, COVID-19 can, in turn, aggravate the damage to the heart.
has issue date	2020-03-11(xsd:dateTime)
bibo:doi	10.1007/s00392-020-01626-9
bibo:pmid	32161990
has license	no-cc
sha1sum (hex)	a8c25a8f628c12291a84d4cd60a0e09826778116
schema:url	https://doi.org/10.1007/s00392-020-01626-9
resource representing a document's title	Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
has PubMed Central identifier	PMC7087935
has PubMed identifier	32161990
schema:publication	Clin Res Cardiol
resource representing a document's body	covid:a8c25a8f628c12291a84d4cd60a0e09826778116#body_text
is schema:about of	named entity 'acute' named entity 'Embase' named entity 'aim' named entity 'severe' named entity 'total' named entity 'studies' named entity 'Methods' named entity 'COVID-19' named entity 'Cardiology' named entity 'Background' named entity 'COVID-19' named entity 'severe' named entity 'COVID-19' named entity 'performed' named entity 'incidence' named entity 'compared' named entity 'metabolic diseases' named entity 'patients' named entity 'prevalence' named entity 'Patients' named entity 'comorbidities' named entity 'metabolic diseases' named entity 'COVID' named entity 'corona virus' named entity 'comorbidities' named entity 'Embase' named entity 'hypertension' named entity 'comorbidities' named entity 'ICU' named entity 'diabetes' named entity 'COVID-19' named entity 'ICU' named entity 'ICU' named entity 'COVID-19' named entity 'cerebrovascular disease' named entity 'Lymphopenia' named entity 'cardiac patients' named entity 'diabetes' named entity 'lung' named entity 'meta-analysis' named entity 'hypertension' named entity 'risk factors' named entity 'statistical significance' named entity 'cardiovascular' named entity 'Shanghai' named entity 'pneumonia' named entity 'ICU' named entity 'ICU' named entity 'infection' named entity 'hypertension' named entity 'nasal cannula' named entity 'SARS-CoV' named entity 'metabolic' named entity 'MCP-1' named entity 'gastrointestinal systems' named entity 'cerebrovascular diseases' named entity 'Wuhan' named entity 'Bo Li' named entity 'COVID-19' named entity 'meta-analysis' named entity 'ICU' named entity 'acute myocardial injury' named entity '2019-nCoV' named entity '163.com' named entity 'hypertension' named entity 'diabetes' named entity 'IP-10' named entity 'epithelial cells' named entity 'diabetes' named entity 'hypertension' named entity 'statistically significant' named entity '2019-nCoV' named entity '9.9' named entity 'ICU'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software